Literature DB >> 20598822

French national health insurance information system and the permanent beneficiaries sample.

P Tuppin1, L de Roquefeuil, A Weill, P Ricordeau, Y Merlière.   

Abstract

In France, in the early 2000s, legislators ordered that the National Health Insurance regime develop an inter-regime information system (SNIIR-AM) aimed at better understanding and evaluating beneficiaries' health care consumption and associated expenditures. In 2009, it contained data from the general health insurance regime that covers 86% of the French population; approximately 53 million people. Data are only available for a period of two years plus the current year. In addition, a permanent sample of health insurance beneficiaries (EGB) was created from the SNIIR-AM database. This is a permanent, representative cross-sectional sample of the population covered by National Health Insurance which, since 2004, monitors beneficiaries' health care consumption over a period of 20 years. It contains anonymous sociodemographic and medical characteristics and records of health care reimbursements. It was created using a systematic sampling method (1/97) on the two-digit control key of beneficiaries' national identification number and includes both current year reimbursement recipients and non-recipients. In 2009, it grouped together almost 500,000 beneficiaries covered by the National Health Insurance Fund for Salaried Workers; 77% of the population residing in France excluding public service employees and students. The EGB is used to conduct longitudinal studies as it permits tracing back patients' care paths and use of care in both hospital and office-based care environments and to calculate individual expenditures. It also permits the study of certain relatively frequent diseases characterised by a 100% reimbursement rate for certain chronic diseases and the reimbursement of tracer drugs. Eventually, the SNIIR-AM will include beneficiaries covered by all the different Health Insurance regimes in France. Copyright 2010. Published by Elsevier Masson SAS.

Entities:  

Mesh:

Year:  2010        PMID: 20598822     DOI: 10.1016/j.respe.2010.04.005

Source DB:  PubMed          Journal:  Rev Epidemiol Sante Publique        ISSN: 0398-7620            Impact factor:   1.019


  88 in total

1.  Trends in use of antipsychotics in elderly patients with dementia: Impact of national safety warnings.

Authors:  Adeline Gallini; Sandrine Andrieu; Julie M Donohue; Naïma Oumouhou; Maryse Lapeyre-Mestre; Virginie Gardette
Journal:  Eur Neuropsychopharmacol       Date:  2013-09-17       Impact factor: 4.600

2.  Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France.

Authors:  J Bezin; A Pariente; R Lassalle; C Dureau-Pournin; A Abouelfath; P Robinson; N Moore; C Droz-Perroteau; A Fourrier-Reglat
Journal:  Eur J Clin Pharmacol       Date:  2013-11-24       Impact factor: 2.953

3.  The economic burden of diabetes to French national health insurance: a new cost-of-illness method based on a combined medicalized and incremental approach.

Authors:  Grégoire de Lagasnerie; Anne-Sophie Aguadé; Pierre Denis; Anne Fagot-Campagna; Christelle Gastaldi-Menager
Journal:  Eur J Health Econ       Date:  2017-02-11

4.  Use of non-conventional medicine two years after cancer diagnosis in France: evidence from the VICAN survey.

Authors:  Aline Sarradon-Eck; Anne-Déborah Bouhnik; Dominique Rey; Marc-Karim Bendiane; Laetitia Huiart; Patrick Peretti-Watel
Journal:  J Cancer Surviv       Date:  2017-02-01       Impact factor: 4.442

5.  Impact of bariatric surgery on the medical management and costs of obese patients in France: an analysis of a national representative claims database.

Authors:  Sébastien Czernichow; David Moszkowicz; Karine Szwarcensztein; Corinne Emery; Antoine Lafuma; Julie Gourmelen; Francis Fagnani
Journal:  Obes Surg       Date:  2015-06       Impact factor: 4.129

6.  Patterns of gabapentin and pregabalin use and misuse: Results of a population-based cohort study in France.

Authors:  Damien Driot; Emilie Jouanjus; Stéphane Oustric; Julie Dupouy; Maryse Lapeyre-Mestre
Journal:  Br J Clin Pharmacol       Date:  2019-03-28       Impact factor: 4.335

7.  Antipsychotic prescribing in youths: a French community-based study from 2006 to 2013.

Authors:  Hélène Verdoux; Elodie Pambrun; Sébastien Cortaredona; Marie Tournier; Pierre Verger
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-01-07       Impact factor: 4.785

8.  Impact of pioglitazone regulatory withdrawal on antidiabetic drug use and health in diabetic patients.

Authors:  Antoine Pariente; Yohann Mansiaux; Ana Jarné; Francesco Salvo; Cécile Pageot; Julien Bezin; Andy Smith; Bernard Bégaud
Journal:  Eur J Clin Pharmacol       Date:  2017-09-02       Impact factor: 2.953

9.  Long-term risk of hip or forearm fractures in older occasional users of benzodiazepines.

Authors:  Hélène Carrier; Sébastien Cortaredona; Viviane Philipps; Hélène Jacqmin-Gadda; Marie Tournier; Hélène Verdoux; Pierre Verger
Journal:  Br J Clin Pharmacol       Date:  2020-05-10       Impact factor: 4.335

10.  A time series study of gastroenteritis and tap water quality in the Nantes area, France, 2002-2007.

Authors:  Pascal Beaudeau; Abdelkrim Zeghnoun; Magali Corso; Agnès Lefranc; Loïc Rambaud
Journal:  J Expo Sci Environ Epidemiol       Date:  2013-02-27       Impact factor: 5.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.